Multicenter cohort study of DNA methylation in risk populations of cervical cancer in Suzhou

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063136

Enrollment

Unknown

Registered

2022-08-31

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

case series:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. No age limit; 2. TCT, hr-HPV typing and colposcopic biopsy results were available; 3. Patients with hr-HPV positive or/and TCT ASCUS+; 4. No immunodeficiency disease; 5. Willing to cooperate with doctors for follow-up treatment and follow-up investigation; 6. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous history of cervical cancer or other malignant tumors; 2. Previous genital warts; 3. Patients cannot correctly express their main complaints, such as mental illness, severe neurosis; 4. Any other factors that the investigator considers inappropriate for subjects to enter the study.

Design outcomes

Primary

Measure	Time frame
DNA Methylation;	—

Countries

China

Contacts

Public ContactChen Youguo

The First Affiliated Hospital of Soochow University

chenyouguo@suda.edu.cn+86 13901547463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026